Diltiazem

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

Analyzing over US$ 90 billion of Medicare Prescription Drug (Part D) Spending in 2016

This week, PharmaCompass reviews the recently released data on prescription drugs paid for under th

Teva to market cannabis inhaler; FDA makes quality metrics voluntary

This week, Phispers brings you news on J&J’s plans to acquire Actelion and Teva’s ne